Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases (NCT05147688)

🧪 Interventions in This Study

• AlloRx (BIOLOGICAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Medical Surgical Associates Center — St John's,

📞 Contact the Study Coordinator

Phone: (847) 699-6810

Email: research@ismoc.net

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Pulmonary Disease

• ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent — Los Angeles, California
• Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis) — Jackson, Mississippi
• DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers — Birmingham, Alabama
• DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer — Los Angeles, California
• Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections — Portland, Oregon
• Natural History Study of Biomarkers in Pulmonary Arterial Hypertension — Bethesda, Maryland

Explore by condition: All Pulmonary Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.